Healthcare / Medical Care FacilitiesToronto
$3.18
-0.07 (-2.15%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $22.5M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$202M
P/E
7.4x
↓EV/EBITDA
9.4x
↓ROE
23.9%
↑Gross Margin
30.0%
↓Debt/Equity
0.71
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.0%
FCF CAGR
+37.2%
FCF margin
6.1%
FCF / Net income
0.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $370.2M · net income $26.1M · FCF $22.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $370.2M | $370.2M | $366.7M | $370.7M | $381.7M |
| Net Income | $26.1M | $26.1M | $-4.5M | $-5.4M | $-34.4M |
| EBITDA | $28.5M | $28.5M | $23.9M | $24.7M | $-610000.00 |
| EPS | 0.41 | 0.41 | -0.07 | -0.09 | -0.72 |
| Gross Margin | 30.0% | 30.0% | 29.5% | 28.2% | 28.8% |
| Operating Margin | 3.2% | 3.2% | 2.0% | 1.9% | 2.0% |
| Net Margin | 7.1% | 7.1% | -1.2% | -1.5% | -9.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.71 | 0.71 | 0.98 | 1.20 | 2.10 |
| Current Ratio | 1.10 | 1.10 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $22.5M | $22.5M | $29.9M | $18.7M | $8.7M |
| Returns | |||||
| ROE | 23.9% | 23.9% | -5.3% | -6.6% | -53.3% |
| Valuation | |||||
| P/E | 7.40 | 7.40 | — | — | — |
| EV/EBITDA | 9.43 | 9.43 | 8.40 | 7.83 | — |
| P/B | 1.87 | 1.87 | 1.51 | 1.25 | 2.22 |
| Growth & Yield | |||||
| Revenue Growth | 1.0% | 1.0% | -1.1% | -2.9% | — |
| EPS Growth | 685.7% | 685.7% | 22.2% | 87.5% | — |
| Dividend Yield | 2.5% | 2.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-11.7%
EPS terminal req.
$0.28
Spread vs growth
697.4%
5Y implied EPS CAGR
-3.6%
EPS terminal req.
$0.34
Spread vs growth
689.3%
10Y implied EPS CAGR
3.0%
EPS terminal req.
$0.55
Spread vs growth
682.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+19.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.07 → 0.41
Residual
+16.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.